The pilots and staff of UAE Team Emirates, the 2020 Tour de France winning team, received the UAE Ministry of Health and Prevention approved COVID-19 vaccine developed by Sinopharm CNBG, following the success of the # 4Humanity trials facilitated by G42 Healthcare in the United Arab Emirates.
This press release is about multimedia. See the full news here: https://www.businesswire.com/news/home/20210108005510/es/
Tour de France 2020 winner Tadej Pogacar receives Covid-19 vaccine in Abu Dhabi, United Arab Emirates (Photo: AETOSWire)
27 riders, including Slovenian cyclist Tadej Pogačar, 2020 Tour de France winner, and 32 staff members have currently received the vaccine.
Mauro Gianetti, Director of UAE Team Emirates, commented on the vaccine: “As part of the UAE team, we are enormously proud of the efforts that the nation and its leadership have made at every level to combat the impacts of the UAE pandemic. COVID-19 and to be a leader in efforts to get back to living a normal life. “
“The entire team is pleased to have had the opportunity to protect themselves and others with the placement of the vaccine, and we would like to congratulate the United Arab Emirates and all partners in this program for their incredible work in making this happen.” .
About G42 Healthcare
G42 Healthcare, a leading technology company and subsidiary of Group 42 based in Abu Dhabi, is committed to developing a world-class and sustainable healthcare sector in the United Arab Emirates. Leading the way in the battle against COVID-19, G42 Healthcare uses its advanced artificial intelligence (AI) techniques and extensive computing resources to accelerate the detection of COVID-19, conduct research on new vaccines and drug therapies. , and map trends in the outbreak, including virus mutations. The company responsible was conducting the world’s first phase III clinical trial of inactivated vaccines throughout the Pan-Arab region with more than 43,000 volunteers of more than 125 nationalities.
* Source: AETOSWire
The original text in the source language of this release is the official authorized version. Translations are only provided as an adaptation and must be checked against the text in the source language, which is the only version of the text that will have legal effect.
View the original version on businesswire.com: https://www.businesswire.com/news/home/20210108005510/en/
Reem Abi Ali, +971559648763